- Joined
- Apr 16, 2004
- Messages
- 4,641
- Reaction score
- 5,022
Relevant background: https://www.astro.org/MACRA/
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) calls for alternative payment models for all Medicare patients effective January 1, 2017. Recent provisions have exempted MDs who see little/no Medicare patients (e.g. cosmetics, concierge medicine). There are two paths that physicians may choose:
1. The Merit-Based Incentive Payment System (MIPS) - continued fee-for-service but with enhanced quality measures
2. An Alternative Payment Model (APM) - higher risk:reward ratio. Practice takes nominal risk, keeps the money over what it costs to implement care; eats costs if they go over.
Our practice's Med Oncs participate in the Oncology Care Model (OCM) so are exempt from MACRA. However we still have Rad Oncs, Surgeons, and PCPS. For Rad Onc, it doesn't appear that APM is mature enough to participate (outside of a few forward-thinking markets) so we will probably head down the MIPS road.
How about the rest of you?
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) calls for alternative payment models for all Medicare patients effective January 1, 2017. Recent provisions have exempted MDs who see little/no Medicare patients (e.g. cosmetics, concierge medicine). There are two paths that physicians may choose:
1. The Merit-Based Incentive Payment System (MIPS) - continued fee-for-service but with enhanced quality measures
2. An Alternative Payment Model (APM) - higher risk:reward ratio. Practice takes nominal risk, keeps the money over what it costs to implement care; eats costs if they go over.
Our practice's Med Oncs participate in the Oncology Care Model (OCM) so are exempt from MACRA. However we still have Rad Oncs, Surgeons, and PCPS. For Rad Onc, it doesn't appear that APM is mature enough to participate (outside of a few forward-thinking markets) so we will probably head down the MIPS road.
How about the rest of you?